La Jolla Pharmaceutical Shares Up 13% Premarket
7:50 AM ET 1/14/20 | Dow Jones
By Michael Dabaie
La Jolla Pharmaceutical Co. (LJPC) shares were up 13%, to $7.90, in premarket trading.
Company director Kevin C. Tang recently acquired about 3 million shares of the company's common stock, according to a filing with the Securities and Exchange Commission.
Write to Michael Dabaie at michael.dabaie@wsj.com
> Dow Jones Newswires
January 14, 2020 07:50 ET (12:50 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.